INOEarnings•prnewswire•
INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Sentiment:Neutral (45)
Summary
On track to submit Biologics License Application (BLA) for INO-3107 in 2H25, with the goal of file acceptance by year end Completed design verification (DV) testing of CELLECTRA® 5PSP device required for BLA submission and requested rolling submission from US Food and Drug Administration...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 12, 2025 by prnewswire